Baird Medical Investment Holdings Ltd revenue

Baird Medical Investment Holdings Ltd's revenue was $22.5m in fiscal 2025, down 39.2% on the year before. Since fiscal 2022 ($35.1m) it has grown at a compound -13.7% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Baird Medical Investment Holdings Ltd: revenue history, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	35	31	37	23
Growth on the year before	—	−10.4%	+17.7%	−39.2%
Gross profit	28	27	33	19
Gross margin	79.9%	86.6%	88.2%	83.8%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Baird Medical Investment Holdings Ltd	$22.5m	-39.2%	—
Sonoma Pharmaceuticals, Inc.	$21.9m	47.0%	19.9%
Vivos Therapeutics, Inc.	$20.9m	45.2%	10.6%
Nephros Inc	$20.7m	24.2%	19.3%
Jin Medical International Ltd.	$20.7m	-12.0%	—
QT Imaging Holdings, Inc.	$26.4m	220.0%	—

Compare with peers

Head to head: BDMD vs SNOA BDMD vs VVOS BDMD vs NEPH BDMD vs QTI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Baird Medical Investment Holdings Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Baird Medical Investment Holdings Ltd.